Smith & Nephew to buy Swiss firm Atracsys
Smith & Nephew on Tuesday said it was buying Switzerland's Atracsys, a provider of optical tracking technology used in computer-assisted surgery, for an undisclosed sum.
FTSE 100
8,280.63
16:49 04/10/24
n/a
n/a
FTSE 350
4,570.17
17:14 04/10/24
n/a
n/a
FTSE All-Share
4,527.24
16:54 04/10/24
n/a
n/a
Health Care Equipment & Services
11,072.28
17:14 04/10/24
-0.21%
-23.76
Smith & Nephew
1,137.00p
16:45 04/10/24
-0.26%
-3.00p
Atracsys' fusionTrack 500 system offers superior measurement speed and latency performance, supporting reduced procedure times, as well as increased accuracy resulting in finer precision surgical tasks, such as bone cuts, compared to existing tracking technology, Smith & Nephew said in a statement.
The acquisition was expected to complete during the third quarter of 2019, it added.